Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.


TSXV:CVM.H - Post by User

Comment by Looneytuneson Jul 12, 2022 9:27am
170 Views
Post# 34817560

RE:RE:RE:RE:RE:RE:Lawsuit

RE:RE:RE:RE:RE:RE:LawsuitVancouver, British Columbia--(Newsfile Corp. - September 2, 2021) - CVR Medical Corp. (TSXV: CVM) (OTC Pink: CRRVF) ("CVR Medical" or the "Company" or "we") a Canadian listed and US based healthcare company in the medical device market is pleased to announce the appointment of Darren Day as Chief Executive Officer (CEO), effective immediately. Mr. Day brings a skill set necessary at this time to move the Company forward; specifically his entrepreneurial background in business management, legal, and financing. Darren has managed a successful law firm for over 14 years. He obtained a bachelor's degree at BYU and continued to law school at UNC Chapel Hill where he graduated with a JD MBA. Through Darren's network, he and the Board feel the Company will be able to secure new capital, which is essential at this time. Mr. Day comes to CVR Medical Corp. with the goal of bringing the Carotid Stenotic Scan (CSS) through FDA clearance. The Board believes that Darren will help the Company make important strides toward a successful introduction of the CSS to the marketplace and with the right strategies and focused execution will be able to unlock CVR Medical's potential.
<< Previous
Bullboard Posts
Next >>